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Recombinant-virus based assays of neutralisation of
HIV-1 envelope are routinely used to measure the sensi-
tivity of viruses to neutralisation, and the ability of sera
to neutralise viral isolates. However, it is difficult to
visualise antigenic differences, especially when the num-
ber of viruses and sera are large. Borrowing from devel-
opments in antigenic cartography in influenza, I present
a statistical model to map viruses and sera into antigenic
space, and apply it to data from five published studies of
HIV-1 neutralisation. After controlling for potential dose
effects, I show that differences in neutralisation of HIV-
1 can be mapped into 1-2 dimensions, as ‘broadly-reac-
tive’ sera typically used in neutralisation studies exhibit
similar patterns of neutralisation across viral isolates.
Antigenic distances generated from the map were asso-
ciated with amino acid substitutions across many sites
scattered over the whole envelope region, suggesting
that antigenic differences between viruses arise due to
multiple mutations of relatively small effect.
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